APOB and familial hypercholesterolemia: The second ASO drug, Mipomersen was for homozygous familial hypercholesterolemia (HoFH), which forms a double-strand complex with apolipoprotein B (APOB) transcript and causes its degradation through ribonuclease RNase H [27].